61 results
8-K
EX-99.1
zlatrriilml2xllen
5 Jan 24
Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-year 2023 Net Revenue Results
6:02am
8-K
EX-99.1
s9kliaw ayxje92qy0g
21 Aug 23
Dr. Daniel G. Billen appointed Chair of the Board of Directors
4:11pm
8-K
EX-99.1
ankntjzebfmc1qnkzc
3 Jul 23
Aurinia Board of Directors Announces Exploration of Strategic Alternatives to Maximize Shareholder Value
6:06am
8-K
EX-99.1
k3n9f84n
10 May 22
Aurinia Reports First Quarter 2022 Financial and Operational Results
6:06am
DEFA14A
93e7xlj6j7
18 Apr 22
Additional proxy soliciting materials
7:36am
S-3ASR
EX-1.2
n579peud3rk6rq9tser
19 Nov 21
Automatic shelf registration
5:04pm
8-K
EX-99.1
7ku0vs ne
17 Aug 21
Riptide Aurinia Collaboration & License Agreement
4:07pm
8-K
EX-99.1
9q6gyez1k 8346e07hqc
17 Jun 21
Aurinia Announces Addition of Dr. Brinda Balakrishnan to the Board of Directors
4:36pm
DEF 14A
ze4g5f37
10 May 21
Definitive proxy
4:06pm